Hypersensitivity and the Lung Flashcards
Autonomic NS
Sympathetic ganglion - within a chain adjacent to the spinal cord.
Parasympathetic ganglion - within or very close to effector organ.
Parasympathetic bronchconstriction
Vagus nerve neurons terminate in the parasympathetic ganglia in the airway wall.
Short nerve fibres reach the muscle and release ACh.
Antimuscarinics
Ipratropium bromidev- can be used as an inhaled treatment to relax airways in asthma and COPD - but short acting antimuscarinic.
LAMAs
Long action - increase bronchodilation and relieve breathlessness in asthma and COPD.
Sympathetic regulation
Activation of beta2 receptors on airway smooth muscle - muscle relaxation.
SABA and LABAs
Short-acting (salbutamol) and long acting (formoterol) beta2 agonists.
Given with steroids for asthma and without for COPD.
Acute rescue of bronchoconstriction.
Adverse effects of B2-agonists
Tachycardia
Hyperglycaemia - loss of insulin sensitivity - increased liver glucose release.
Hypersensitivity
Type I - IgE antibodies - immediate - Anaphylaxis, Hayfever.
Type II - Cytotoxic, Antibodies bound to cell antigen - hours to days -Transfusion reactions.
Type III - Deposition of immune complexes - Typically 7 – 21 days - Hypersensitivity pneumonitis; lupus; post streptococcal Glomerulonephritis.
Type IV - T-cells (lymphocytes) - Days to weeks or months - Tuberculosis;
Stevens-Johnson syndrome.
Antibodies
IgM: Circulating tetramers made at the beginning of infection.
IgG: Monomer highly specific antibodies targeting single epitopes.
IgE: Likely to have developed in response to parasitic threats. Implicated in allergy, particularly alongside eosinophils
IgA: Expressed in mucosal tissue. Forms dimers. Protects the neonatal gut (expressed in breast milk).
IgD: Monomers, induction of antibodies in B cells, activates basophils and mast cells.
Type 1
Antigen interacts with IgE bound to mast cells or basophils.
Degranulation of mediators lead to local effects.
Histamine the predominant mediator.
Anaphylaxis
GIVE ADRENALINE
Type II
Antibodies reacting with antigenic determinants on the host cell membrane.
Usually IgG or IgM.
Outcome depends on whether complement is activated and if metabolism of cell is affected.
Type III
Antigen-immunoglobulin complexes are formed on exposure to the allergen.
These are deposited in tissues and cause local activation of complement and neutrophil attraction.
Type IV
T-cell mediated, releasing IL2, IFᵧ and other cytokines.
Requires primary sensitisation.
Secondary reaction takes 2-3 days to develop.
May result from normal immune reaction – if macrophages cannot destroy pathogen, they become giant cells and form granuloma.